Darbepoetin alfa is more potent in vivo and can be administered less frequently than rHuEPO. (Q46826215)
Jump to navigation
Jump to search
scientific article published in August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Darbepoetin alfa is more potent in vivo and can be administered less frequently than rHuEPO. |
scientific article published in August 2002 |
Statements
1 reference
Darbepoetin alfa is more potent and can be administered less frequently than rHuEPO (English)
J Egrie
1 August 2002
1 reference